Aakalu Girish N
- SEC CIK
- 0001761614
No open-market purchases or sales filed in the past year.
Current role at each company
- GNCA Genocea Biosciences, Inc.CHIEF BUSINESS OFFICERas of Apr 5, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Aakalu Girish N as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Aakalu Girish NCHIEF BUSINESS OFFICER | SSale | −963 | $1.25 | −$1.20K | −1.3%74.5K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Aakalu Girish NCHIEF BUSINESS OFFICER | SSale | −2.40K | $1.10 | −$2.64K | −3.1%75.4K after |